Focal Therapy for Renal Cancer: Comparative Trends in the USA and Germany from 2006 to 2020 and Analysis of the German Health Care Landscape.
Ablation techniques
Focal therapy
Kidney
Population-based study
Renal cell carcinoma
Trends
Journal
Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
10
2022
accepted:
01
12
2022
medline:
29
5
2023
pubmed:
27
1
2023
entrez:
26
1
2023
Statut:
ppublish
Résumé
The aim of the study was to investigate trends of FT for in-patient treatment of renal RCC in the USA and Germany. We analyzed the SEER database for the USA and the nationwide German hospital billing database each from 2006 to 2019 for a RCC diagnosis in combination with FT, radical nephrectomy, and partial nephrectomy. FT was defined as radiofrequency ablation (RFA) or cryotherapy. Linear regression analysis was performed to detect changes over time. For the USA, we included 7,318 FT cases. The share of FT increased from 2.4% in 2006 to 6.4% in 2019 (p < 0.001). For Germany, we identified 2,920 FT cases. The share of FT increased from 0.7% in 2006 to 2.0% in 2019 (p < 0.001). The number of RFAs in the USA steadily increased by 227% from a total of 93 in 2006 to 304 in 2019 while the number of cryotherapies in the USA steadily increased by 289% from a total of 127 in 2006 to 494 in 2019 (p < 0.001). The number of RFAs in Germany increased by 344% from a total of 59 in 2006 to 262 in 2019 (p < 0.001) while the number of cryotherapies steadily increased by 43% from a total of 54 in 2006 to 77 in 2019 (p < 0.001). In Germany, RFA is significantly more performed than cryotherapy while in the USA cryotherapy is more frequently applied. We observed a constant increase of FT in the USA and Germany for RCC in-patient treatment with a higher share in the USA.
Identifiants
pubmed: 36702105
pii: 000528559
doi: 10.1159/000528559
pmc: PMC10210078
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
396-405Informations de copyright
© 2023 The Author(s). Published by S. Karger AG, Basel.
Références
J Urol. 2004 Sep;172(3):874-7
pubmed: 15310987
Radiology. 2003 Feb;226(2):417-24
pubmed: 12563135
Invest Radiol. 1990 Mar;25(3):267-70
pubmed: 2185179
Eur Urol. 2012 Jun;61(6):1156-61
pubmed: 22257424
Ann Surg Oncol. 2020 Jun;27(6):1920-1928
pubmed: 31823172
Eur Urol Open Sci. 2022 Apr 01;39:22-28
pubmed: 35528783
JAMA Intern Med. 2018 Feb 1;178(2):221-227
pubmed: 29279887
Eur Urol. 2018 Aug;74(2):157-164
pubmed: 29625756
Eur Urol. 2007 Feb;51(2):348-57
pubmed: 17084513
J Urol. 2017 Sep;198(3):520-529
pubmed: 28479239
Urology. 2000 Nov 1;56(5):748-53
pubmed: 11068292
J Endourol. 2020 Dec;34(12):1211-1217
pubmed: 32292059
Cardiovasc Intervent Radiol. 2021 Dec;44(12):2022-2025
pubmed: 34414496
Abdom Radiol (NY). 2022 Feb;47(2):885-890
pubmed: 34958404
Am Surg. 1999 Nov;65(11):1009-14
pubmed: 10551746
Eur Urol. 2022 Oct;82(4):399-410
pubmed: 35346519
Cryobiology. 2014 Feb;68(1):1-11
pubmed: 24239684
Eur Urol. 2019 Jan;75(1):74-84
pubmed: 30243799
Br J Urol. 1995 Feb;75(2):132-6; discussion 136-7
pubmed: 7850315
J Endourol. 2015 Jun;29(6):671-6
pubmed: 25386995
J Urol. 2001 Mar;165(3):773-6
pubmed: 11176465
World J Urol. 2022 Jul;40(7):1645-1652
pubmed: 35562598
J Urol. 2019 Feb;201(2):251-258
pubmed: 30634350
Eur Radiol. 2019 Mar;29(3):1293-1307
pubmed: 30255245
Semin Intervent Radiol. 2019 Aug;36(3):183-193
pubmed: 31435126
AJR Am J Roentgenol. 2011 Apr;196(4):935-9
pubmed: 21427348
BJS Open. 2017 Jul 26;1(2):50-54
pubmed: 29951606
J Clin Oncol. 2018 Oct 29;36(36):3591-3600
pubmed: 30372390